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Separation delay of whole blood
A B S T R A C T
Capillary blood collected in serum tubes was subjected to centrifugation delay while stored at room temperature.
Chlamydia trachomatis (CT) IgG concentrations in aliquoted serum of these blood samples remained stable for
seven days after collection. CT IgG concentrations can reliably be measured in mailed blood samples in epi-
demiological studies.
Implementing Chlamydia trachomatis (CT) antibody testing in large
cohort studies increases insight in CT infection history. CT-infections
are often missed due to the asymptomatic nature of the infection
(Center for Disease Control and Prevention, 2014; Davies et al., 2016;
Low et al., 2007), however 40–100% of women test positive for CT
antibodies after CT-infection (Clad et al., 2000; Gijsen et al., 2002;
Horner et al., 2013; Morre et al., 2002). Using antibody testing in-
creases insight in CT infection history compared to only using self-re-
ported CT infection history or test for prevalent infection (Johnson and
Horner, 2008). Therefore, the Netherlands Chlamydia Cohort Study
(NECCST), a large cohort study determining the risk of CT related
complications, uses antibody testing to determine CT infection history
(Hoenderboom et al., 2017). To test for CT antibodies in NECCST a low
cost, practical and reliable blood collection method was required (Clark
et al., 2003).
The most practical collection method is capillary blood drawing by
participants at home. Collected blood can be sent back to the laboratory
by regular mail (Hoenderboom et al., 2017; Holland et al., 2003). Blood
can either be collected on filter paper or in capillary blood collection
tubes with serum separator additive. Previously CT IgG was tested for
validation using dried blood spots (DBS) versus clinician derived reg-
ular serum collected for a study to validate HIV, HBV and syphilis
screening. DBS were validated for HIV, HBV and syphilis (van Loo et al.,
2017), but failed when we tested for CT IgG. High background distor-
tion gave false positive results (89–100%) when compared to regular
serum in assays from two different manufacturers (Medac, Wedel,
Germany and Savyon Diagnostics, Israel). By varying the dilution
factor, failure rates were reduced but still up to 25%. Because of the
high failure rates in DBS, we switched to an evaluation of collecting
capillary blood in collection tubes as we were then able to perform the
CT IgG test with regular serum (Liu et al., 2017).
Liquid capillary whole blood sent by regular mail cannot be sepa-
rated from cells within the recommend 2 h after blood is collected.
Separation delay could result in clot-induced changes, possibly altering
the analyte concentration in serum (Holland et al., 2003). Previous
studies on delayed separation of whole blood showed that for a variety
of analytes, samples could be stored for up to a week with only slight
concentration alterations (Clark et al., 2003; Ikeda et al., 2015).
We determined CT IgG stability in three paired capillary blood
samples newly collected in serum gel tubes (BD Microtainers with clot
activator and serum separator gel) exposed to room temperature for
2 h, four days and seven days prior to centrifugation to simulate mail
times. If CT IgG stability remained stable after four and seven days at
room temperature, CT IgG concentrations could reliably be used in
epidemiological studies on Chlamydia trachomatis.
Samples were collected from NECCST's participants. In NECCST,
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women with and without a positive CT infection history are pro-
spectively followed for at least 10 years until 2022 (Hoenderboom
et al., 2017). A preselected subset of women with known CT infection
history (positive/negative) was asked to participate in this validation
study. We aimed for at least 20 respondents. The study was approved by
the Medical Ethical Committee Noord-Holland, Alkmaar (NL
51553.094.14/M014-042).
To test CT IgG stability, three paired samples were collected during
one appointment by a medical professional at the VU University med-
ical center in Amsterdam, The Netherlands, or at participant's home.
Blood was collected via finger prick in BD Microtainer® blood collection
tubes with clot activator and serum separator additive (SST) (Ref.
365967). We aimed for at least five droplets of whole blood per col-
lection tube. The collected blood was stored at room temperature
(21 °C) before centrifugation for different time intervals based on (de-
layed) mail delivery time. The first sample (the baseline sample, t0) was
centrifuged in accordance with the guideline standard of 2 h (t0), a
second sample was stored for either 3, 4 or 5 days (t1), and the last
sample was stored for seven days (t2). Following centrifugation, ali-
quoted serum was stored at −20 °C until analysis. Prior to analysis,
frozen serum samples were thawed at room temperature and inverted
several times. To avoid run-to-run variability, serum samples from all
time points (t0, t1 and t2) per participant were analyzed together in one
batch and all samples were tested in duplicate.
The CT IgG ELISA plus (CT IgG ELISA plus; Medac, Wedel,
Germany) assay was used to test for CT antibodies. This is a quantitative
peptide based serological assay. The ELISA was used according to the
manufacturer's instructions. The mean outcome of the duplicates per
sample was used in further analyses. Outcomes were reported as ne-
gative (IgG concentration < 22 AU/ml), grey-zone (IgG concentration
22–28 AU/ml), or positive (IgG concentration ≥ 28 AU/ml), and
quantitative in IgG concentration (AU/ml).
Laboratory results were entered in Microsoft Excel and analyzed
using STATA, (version 14.2; StataCorp, College Station, TX, USA).
Samples centrifuged at different time intervals (t1 and t2) were com-
pared to the baseline sample (t0). Results were first analyzed as ordinal
(i.e. negative, grey-zone and positive) using Kappa values, which in-
dicates the level of agreement. And for calculation of the sensitivity,
specificity, positive predictive value (PPV), and negative predictive
value (NPV), grey-zones were classified as positive in accordance with
NECCST protocol (Hoenderboom et al., 2017). Second, IgG concentra-
tions from paired samples were analyzed using r2's to indicate the
proportion of the variance between the baseline samples versus other
time points. Additionally, Bland-Altman plots were constructed to
analyze the agreement between the different time points in CT IgG
concentration (Altman and Bland, 1983). For the Bland Altman plots
upper and lower agreement limits were predefined as the margin of the
grey-zone, which is −6 and 6 AU/ml (Bland and Altman, 1999;
Giavarina, 2015). We chose 6 AU/ml because paired samples may not
differ> 6 AU/ml otherwise negative samples could turn positive and
vice versa.
Due to the association between the difference of paired samples and
the size of the measurements, raw data (including upper and lower
agreement limits) were log transformed for use in Bland Altman plots
(Scott et al., 2003).
In total, we obtained blood from 35 women. The average age was
31.6 years (range 24–37 years) and the majority was of Western eth-
nicity, 77%. Twenty-one women (60%) had a positive CT infection
history either by previous positive test result or self-reported. One
woman had a gonorrhoea infection in the past. We collected 98 sam-
ples, an average of 2.8 per woman. Seven women provided only two
paired samples instead of three; the second sample was stored for either
four days (n = 2) or seven days (n = 5). The amount of whole blood
collected was generally small resulting in samples with a median of
40 μl serum (IQR 28.5–50.0 μl) per collection tube. Of the 35 baseline
samples, 15 (42.9%) were CT IgG positive, 5 (14.3%) were grey-zones
and 15 (42.9%) were negative.
Kappa values between t0 samples and, t1 and t2 samples indicated
high level of agreement: 0.83 and 0.90 respectively. Three samples
from the t1 and two samples from the t2 differed in outcome from t0
(Table 1). When grey-zones were classified as positive, only one sample
was discordant. Using the latter definition sensitivity, specificity, PPV
and NPV were calculated (Table 2).
Fig. 1 shows the concentration of the baseline samples compared to
the concentration of the t1 and t2 samples, r2's were both 0.99. Bland
Altman plots show all values to be within the predefined limits of
agreement.
This is the first study to investigate stability of CT IgG concentration
in samples with separation delay stored in BD Microtainers. The SST
tubes cause blood to clot rapidly, enabling the separation of the blood
clot from serum (Bowen and Remaley, 2014). The high sensitivity,
specificity, PPV, and NPV and r2's of almost one showed that CT IgG
concentrations in serum remain stable up to seven days after whole
blood collection. Therefore, this method can be used in epidemiological
studies.
In this study, samples were stored in the laboratory to simulate
delayed mail times, but kept in temperature controlled rooms. In the
actual NECCST cohort, samples are sent using regular mail; this means
Table 1
Baseline sample CT IgG outcomes compared to CT IgG outcomes from samples stored for four and seven days.
Baseline sample (t0) Four days delay (t1)
n(%)
N Seven days delay (t2)
n(%)
N
Positive Grey-zone Negative Total Positive Grey-zone Negative Total
Positive 13 (100.0) 0 (0.0) 0 (0.0) 13 14 (93.3) 1 (6.7) 0 (0.0) 15
Grey-zone 2 (50.0) 2 (50.0) 0 (0.0) 4 1 (25.0) 3 (75.0) 0 (0.0) 4
Negative 0 (0.0) 1 (7.7) 12 (92.3) 13 0 (0.0) 0 (0.0) 14 (100.0) 14
Total 15 (50.0) 3 (10.0) 12 (40.0) 30 15 (45.5) 4 (12.1) 14 (42.4) 33
Table 2
Sensitivity, specificity, positive predictive value and negative predictive value.








t1 30 17 1 12 0 94 100 100 92
t2 33 19 0 14 0 100 100 100 100
a For these analyses grey zone values were considered as positive values. PPV = positive predictive value. NPV = negative predictive value.
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samples will be exposed to more variable temperatures, including day/
night and day-to-day differences, which may result in lower stability.
However, other studies determining the effect of centrifugation delay
on a variety of analytes that compared various storage temperatures,
also showed that total protein levels, including IgG levels, often only
change by a few percentages after 24 h to seven days of delay (Clark
et al., 2003; Tanner et al., 2008).
Home-collected biological materials such as urine samples and va-
ginal swab samples are already implemented in CT studies and
screening (Doshi et al., 2008; Hocking et al., 2013; Morre et al., 1999;
van den Broek et al., 2012). Home-sampling increases participation
rates and provides a less costly alternative for clinic-testing. Even
though only small amounts of blood can be collected, in general this
proved to be enough to perform reliable serology tests for detection of
CT IgG antibodies. Following results of this study, we conclude blood
collected at home in collection tubes and sent to laboratories can re-




Research grant from the National Institute for Public Health and the
Environment (RIVM) (V/150019/17/SA), Bilthoven, The Netherlands.
Availability of data and materials
On request, (anonymized) data and available biological material
can be provided for research related to STI, after approval by an ad-
visory committee.
References
Altman, D.G., Bland, J.M., 1983. Measurement in medicine: the analysis of method
comparison studies. J. R. Stat. Soc. 32 (3), 307–317. http://dx.doi.org/10.2307/
2987937.
Bland, J.M., Altman, D.G., 1999. Measuring agreement in method comparison studies.
Stat. Methods Med. Res. 8 (2), 135–160. http://dx.doi.org/10.1177/
096228029900800204.
Bowen, R.A., Remaley, A.T., 2014. Interferences from blood collection tube components
on clinical chemistry assays. Biochem. Med. (Zagreb) 24 (1), 31–44. http://dx.doi.
org/10.11613/BM.2014.006.
van den Broek, I.V., van Bergen, J.E., Brouwers, E.E., Fennema, J.S., Gotz, H.M., Hoebe,
C.J., Koekenbier, R.H., Kretzschmar, M., Over, E.A., Schmid, B.V., Pars, L.L., van
Ravesteijn, S.M., van der Sande, M.A., de Wit, G.A., Low, N., Op de Coul, E.L., 2012.
Effectiveness of yearly, register based screening for chlamydia in the Netherlands:
controlled trial with randomised stepped wedge implementation. BMJ 345, e4316.
http://dx.doi.org/10.1136/bmj.e4316.
Center for Disease Control and Prevention, 2014. Recommendations for the laboratory-
based detection of Chlamydia trachomatis and Neisseria gonorrhoeae—2014. MMWR
Recomm. Rep. 63 (RR-02), 1–19.
Clad, A., Freidank, H.M., Kunze, M., Schnoeckel, U., Hofmeier, S., Flecken, U., Petersen,
E.E., 2000. Detection of seroconversion and persistence of Chlamydia trachomatis
antibodies in five different serological tests. Eur. J. Clin. Microbiol. Infect. Dis. 19
(12), 932–937.
Clark, S., Youngman, L.D., Palmer, A., Parish, S., Peto, R., Collins, R., 2003. Stability of
plasma analytes after delayed separation of whole blood: implications for epide-
miological studies. Int. J. Epidemiol. 32 (1), 125–130. http://dx.doi.org/10.1093/
ije/dyg023.
0 50 100 150 200
4th day CT IgG concentration (AU/ml)
R-squared=0.9957
4th day sample
0 50 100 150 200
7th day CT IgG concentration (AU/ml)
R-squared=0.9959
7th day sample
0 50 100 150 200
Average of paired merasurements
Bland Altman plot: 4th day sample
0 50 100 150 200
Average of paired measurements




































































































































































Fig. 1. Graphs A and C show scatterplots with regression lines of baseline sample concentrations plotted against 4th day (A) and 7th day (C) delayed samples including r-squared
coefficients. Graphs B and D show Bland-Altman plots, based on log-transformed data, in which elog difference between the baseline sample and 4th day (B) or 7th day (D) sample
concentration were plotted against the average of paired measurements. Upper and lower limits (dashed lines) in the Bland-Altman plots were based on clinically relevant elog(−6 and 6
AU/ml) values.
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